4
Changes in Ownership
Cardiff Oncology, Inc. Filed Acc 0001104659-20-075234
Options or other derivatives
- Chief Executive Officer acquired 221,241 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
Table II: Derivative
| Insider | Date | Transaction | Shares | Price | Value | Exercise | Expires | Underlying | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|
| Erlander Mark Chief Executive Officer | 2020-06-17 | Grant or award · Stock Options | +221,241 | 380,200 | D: show line 1 in the form |
Loading xslF345X03/a4.xml…